160 128

Cited 1 times in

Prognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy

DC Field Value Language
dc.contributor.author박은정-
dc.contributor.author배명일-
dc.contributor.author송영-
dc.contributor.author한동우-
dc.contributor.author함성연-
dc.contributor.author박수정-
dc.date.accessioned2023-11-28T03:12:53Z-
dc.date.available2023-11-28T03:12:53Z-
dc.date.issued2023-10-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/196757-
dc.description.abstractBackground: Bioelectric impedance analysis (BIA)-measured body composition and nutritional status have been used as prognostic indicators in various cancer cohorts. This study investigated whether BIA could provide information on prognosis in peritoneal carcinomatosis patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Methods: We retrospectively analyzed the data of 99 patients with preoperative BIA data among those who underwent CRS and HIPEC. The association between BIA-derived parameters and intraoperative peritoneal cancer index (PCI) score was assessed. Predictive analysis for the occurrence of postoperative morbidities including major complications (Clavien-Dindo classification 3-4) and re-admission within 30 days after surgery as well as 1 year mortality was also performed. Results: BIA-derived mineral (r = 0.224, p = 0.027), fat (r = - 0.202, p = 0.048), and total body water (TBW)/fat-free mass (FFM) (r = - 0.280, p = 0.005) showed significant associations with intraoperative PCI score. Lower TBW/FFM was an independent predictor of major postoperative complications (OR 0.047, 95% CI 0.003-0.749, p = 0.031) and re-admission (OR 0.094, 95% CI 0.014-0.657, p = 0.017) within 30 days after surgery. Higher fat mass was also independently associated with a higher risk of major postoperative complications (OR 1.120, 95% CI 1.006-1.248, p = 0.039) and re-admission (OR 1.123, 95% CI 1.024-1.230, p = 0.013). Intraoperative PCI score > 20 (OR 4.489, 95% CI 1.191-16.917, p = 0.027) and re-admission within 30 days after surgery (OR 5.269, 95% CI 1.288-21.547, p = 0.021) independently predicted postoperative 1-year mortality. Conclusions: We demonstrate that preoperative BIA-derived TBW/FFM and fat mass were significantly correlated with metastatic extent, assessed by PCI score, in patients with peritoneal carcinomatosis. In addition, BIA-derived TBW/FFM and fat mass showed independent predictability for postoperative 30-day major complications and re-admission in patients undergoing CRS and HIPEC. Our findings suggest that assessment of BIA may improve discrete risk stratification in patients who are planned to receive CRS and HIPEC.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.languageEnglish-
dc.publisherBioMed Central-
dc.relation.isPartOfWORLD JOURNAL OF SURGICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAntineoplastic Combined Chemotherapy Protocols / therapeutic use-
dc.subject.MESHCombined Modality Therapy-
dc.subject.MESHCytoreduction Surgical Procedures / adverse effects-
dc.subject.MESHHumans-
dc.subject.MESHHyperthermia, Induced*-
dc.subject.MESHHyperthermic Intraperitoneal Chemotherapy-
dc.subject.MESHPeritoneal Neoplasms* / pathology-
dc.subject.MESHPostoperative Complications / etiology-
dc.subject.MESHPrognosis-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHSurvival Rate-
dc.titlePrognostic role of body composition in peritoneal carcinomatosis patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학교실)-
dc.contributor.googleauthorYoung Song-
dc.contributor.googleauthorMyung Il Bae-
dc.contributor.googleauthorDong Woo Han-
dc.contributor.googleauthorEun Jung Park-
dc.contributor.googleauthorSujung Park-
dc.contributor.googleauthorSung Yeon Ham-
dc.identifier.doi10.1186/s12957-023-03233-0-
dc.contributor.localIdA04572-
dc.contributor.localIdA05774-
dc.contributor.localIdA02036-
dc.contributor.localIdA04274-
dc.contributor.localIdA05192-
dc.relation.journalcodeJ02803-
dc.identifier.eissn1477-7819-
dc.identifier.pmid37891626-
dc.subject.keywordBioelectrical impedance analysis-
dc.subject.keywordHyperthermic intraperitoneal chemotherapy-
dc.subject.keywordPrognosis-
dc.contributor.alternativeNamePark, Eun Jung-
dc.contributor.affiliatedAuthor박은정-
dc.contributor.affiliatedAuthor배명일-
dc.contributor.affiliatedAuthor송영-
dc.contributor.affiliatedAuthor한동우-
dc.contributor.affiliatedAuthor함성연-
dc.citation.volume21-
dc.citation.number1-
dc.citation.startPage345-
dc.identifier.bibliographicCitationWORLD JOURNAL OF SURGICAL ONCOLOGY, Vol.21(1) : 345, 2023-10-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.